Introduction
Custom peptide synthesis is a cornerstone service for biomedical research, drug discovery, and diagnostic development. However, pricing from different manufacturers can vary by 5–10x for what appears to be the same product. Understanding what drives the cost of custom peptide synthesis empowers researchers and procurement managers to budget accurately, evaluate quotes fairly, and optimize their peptide specifications for the best value.
This article breaks down every cost factor in custom peptide synthesis pricing, from sequence length to post-synthesis modifications, scale, and purity requirements.
Factor 1: Sequence Length — The Primary Cost Driver
The number of amino acids in your target peptide is the single largest determinant of synthesis cost. Peptide synthesis via Fmoc solid-phase peptide synthesis (SPPS) is a sequential process where each amino acid addition adds material and labor costs.
How Length Affects Cost
| Sequence Length | Cost per Residue | Typical Base Price (1 mg, crude) | Key Considerations |
|---|---|---|---|
| 2–5 aa | Low | $30–60 | Minimal reagent consumption; easy coupling |
| 6–12 aa | Moderate | $60–120 | Standard synthesis cycle |
| 13–20 aa | Moderate-High | $120–250 | May require double coupling for difficult residues |
| 21–30 aa | High | $250–500 | Compounding yield loss begins to matter |
| 31–45 aa | Very High | $500–1,200 | Significant HPLC purification challenges |
| 46–60 aa | Premium | $1,200–2,500+ | Requires specialized expertise; native chemical ligation may be needed |
The compounding yield problem: Each coupling step has an efficiency of 99.0–99.5%. For a 10-mer, overall yield is approximately 90–95%. For a 40-mer, it drops to 67–82%. This means more starting resin, more reagents, and more purification passes — all adding cost.
Cost-Optimization Tip
If your sequence can be shortened while retaining biological activity (e.g., identifying the minimal active fragment through truncation studies), the cost savings can be dramatic. A 12-mer costs roughly 20–30% of a 30-mer at the same purity.
Factor 2: Purity Grade — Diminishing Returns
Purity specification directly determines the number of HPLC purification rounds and the final yield. Most manufacturers offer tiered pricing based on purity targets:
| Purity Grade | HPLC Passes | Yield Loss | Price Multiplier (vs. Crude) |
|---|---|---|---|
| Crude (~70%) | 0 | 0% | 1.0x (baseline) |
| ≥80% | 1 prep run | 15–25% | 1.2–1.5x |
| ≥85% | 1 optimized run | 25–35% | 1.5–2.0x |
| ≥90% | 2 runs | 35–50% | 2.0–3.0x |
| ≥95% | 2–3 runs | 50–65% | 3.0–5.0x |
| ≥98% | 3–4 runs | 65–80% | 5.0–8.0x |
| ≥99% | 4+ runs + polishing | 80–90% | 8.0–15.0x |
The price-to-purity curve is nonlinear. An additional 1% purity above 98% costs significantly more than the first 1% above crude. For most research applications, 95% purity delivers excellent results at a fraction of the cost of 99%.
Purity Recommendations by Application
– ELISA / screening: ≥85% is often sufficient – Cell culture / functional assays: ≥95% – In vivo animal studies: ≥95% (≥98% preferred for sensitive models) – X-ray crystallography / NMR: ≥98% – Clinical / GMP: ≥99% with full impurity profiling
Factor 3: Modifications — The Hidden Cost Multipliers
Standard linear peptides are the baseline. Any modification — whether at the N-terminus, C-terminus, side chain, or backbone — adds cost via specialized reagents, additional purification, and quality control.
Common Modifications and Their Cost Impact
| Modification | Cost Addition | Complexity Level |
|---|---|---|
| C-terminal amidation | +5–10% | Low — standard procedure |
| N-terminal acetylation | +5–10% | Low — done on-resin |
| Biotinylation (N-terminal or Lys) | +30–60% | Moderate — specialized building block, light sensitivity |
| PEGylation (single PEG chain) | +20–50% | Moderate — PEG reagent cost, additional QC |
| Fluorescent labeling (FITC, FAM, TAMRA) | +50–100% | High — light-sensitive handling, two-step conjugation |
| Phosphorylation (Ser/Thr/Tyr) | +30–60% per site | Moderate — phosphoamino acid building blocks are expensive |
| Disulfide bridge (single) | +20–40% | Moderate — oxidation step, LC-MS verification |
| Multiple disulfide bridges (2+) | +50–100% | High — complex oxidation strategies, significant yield loss |
| Cyclization (head-to-tail) | +30–60% | Moderate — orthogonal protection, on-resin cyclization |
| Lipidation (palmitoyl, myristoyl) | +25–50% | Moderate — reduced solubility complicates synthesis/purification |
| D-amino acid substitution | +10–20% | Low — building block cost only |
| Isotopic labeling (¹³C, ¹⁵N) | +200–500% | Very High — expensive labeled amino acids |
| KLH/BSA conjugation | +40–80% | Moderate — conjugation chemistry, purification, and QC |
Cost Impact of Multiple Modifications
Modifications are additive but not strictly linear. A peptide with both a disulfide bridge and a C-terminal amide will cost the base peptide price + 20–40% (disulfide) + 5–10% (amide) — but some of the process steps overlap, so manufacturers may offer a bundled discount.
Cost-Optimization Tip
If budget is constrained, consider ordering the peptide with a single modification that captures the key biological requirement (e.g., N-terminal acetylation for stability) and perform additional modifications in-house if you have the capability.
Factor 4: Scale (Quantity Ordered)
Bulk discounts apply across custom peptide synthesis, but the cost-per-mg reduction is not uniform. Fixed costs (setup, sequence verification, QC) are distributed across the batch.
| Quantity | Cost per mg (Relative) | Typical Price Range (15-mer, ≥95%) |
|---|---|---|
| 1 mg | 100% | $150–300 |
| 5 mg | 60–80% | $200–450 |
| 10 mg | 45–60% | $250–600 |
| 25 mg | 35–50% | $300–750 |
| 50 mg | 25–40% | $400–1,000 |
| 100 mg | 20–30% | $500–1,200 |
| 500 mg | 15–25% | $1,500–3,500 |
| 1 g | 10–20% | $2,500–6,000 |
| 5 g | 8–15% | $8,000–20,000 |
| 10 g+ | 5–12% | $15,000–40,000 |
Key insight: The fixed cost of QC (HPLC + MS analysis) is approximately $50–100 per batch regardless of scale. For very small quantities (1–5 mg), QC represents a disproportionate share of the total cost.
Multi-Batch vs. Single Large Batch
For projects requiring cumulative quantities exceeding 1 g, a single large synthesis run yields a lower cost per mg than multiple small batches. However, be aware of stability considerations — if your peptide degrades in solution over months, ordering multiple smaller batches at ~500 mg may be more practical.
Factor 5: Timeline (Lead Time and Rush Charges)
Standard custom peptide synthesis lead times are 2–4 weeks from sequence confirmation. Rush orders compress this timeline but require premium pricing:
| Lead Time | Price Premium | When to Use |
|---|---|---|
| 3–4 weeks (Standard) | 0% | Most projects — plan ahead |
| 2 weeks (Accelerated) | +15–25% | Grant deadlines, conference presentations |
| 7–10 days (Rush) | +30–50% | Time-sensitive experiments |
| 3–5 days (Express) | +60–100% | Critical path dependency |
| 24–48 hours (Emergency) | +100–200% | Only for make-or-break experiments |
Rush charges cover:
– Dedicated synthesizer time slot scheduling
– Overtime labor (synthesis typically runs 24/7 in rush mode)
– Expedited QC (dedicated HPLC-MS unit)
– Potential yield reduction — faster purification cycles are less efficient
Factor 6: Counterion (Salt Form)
This is often overlooked but can affect both price and biological compatibility:
| Counterion | Cost Impact | Suitability |
|---|---|---|
| TFA (trifluoroacetate) | Baseline | Acceptable for most in vitro and in vivo work; TFA can interfere with NMR and some cell-based assays |
| Acetate | +10–20% | Preferred for cell culture; more biologically compatible |
| HCl | +15–25% | Highest biocompatibility; more complex lyophilization process |
Factor 7: Documentation and Regulatory Grade
| Documentation Level | Price Premium | Includes |
|---|---|---|
| Standard COA | 0% (included) | HPLC chromatogram, MS spectrum, sequence confirmation |
| Enhanced COA | +5–10% | Quantitative amino acid analysis, water content (KF), residual solvents |
| Stability study | +15–30% | Real-time stability data at specified storage conditions (typically 3–6 months) |
| GMP documentation | +50–200% | Full batch records, raw material traceability, deviation reports, environmental monitoring |
| Drug Master File (DMF) | +$5,000–20,000 | Regulatory submission-ready documentation |
Factor 8: Synthesis Difficulty — The Hidden Variable
Some sequences are inherently difficult to synthesize regardless of length. Manufacturers adjust pricing for:
– Hydrophobic sequences — Poor solvation in standard DMF/NMP solvents, causing aggregation on-resin – Beta-sheet forming sequences — Interchain aggregation during synthesis – Sequences with multiple proline residues — Cis/trans isomerism slows coupling – Sequences with aspartimide-forming motifs — Asp-Gly, Asp-Ser, Asp-Thr require special protection – Sequences with multiple arginine residues — Guanidino protection/deprotection challenges
A “difficult” sequence may cost 2–3x more than a “standard” sequence of the same length.
Real-World Cost Comparison: Three Example Scenarios
Scenario A: Simple Screening Peptide
– Sequence: 12-mer, linear, no modifications
– Purity: ≥85%
– Quantity: 5 mg
– Lead time: Standard
– Estimated cost: $120–200
Scenario B: Modified Peptide for In Vivo Study
– Sequence: 20-mer, C-terminal amide, N-terminal acetylation, single disulfide bridge
– Purity: ≥95%
– Quantity: 50 mg
– Lead time: 2 weeks
– Estimated cost: $800–1,500
Scenario C: Complex Multi-Modified Peptide
– Sequence: 35-mer, PEGylated, biotinylated, with two disulfide bridges
– Purity: ≥98%
– Quantity: 100 mg
– Lead time: Rush (7 days)
– Counterion: Acetate
– Estimated cost: $5,000–12,000
How to Get the Best Price Without Compromising Quality
1. Be precise about purity needs — Don’t order ≥98% if ≥95% will work. The cost difference is substantial. 2. Sequence truncation studies — Identify the minimal active sequence before ordering full-length synthesis. 3. Batch consolidation — If multiple labs need the same peptide, combine orders. 4. Long-term contracts — For ongoing needs, 6-month or 12-month supply commitments unlock volume discounts. 5. Optimize modifications — Add only modifications essential to your experiment. 6. Choose the right manufacturer — Chinese manufacturers like AmPepitide can offer significant cost advantages (30–60% lower) over US/European suppliers while maintaining equivalent quality standards with full analytical documentation. 7. Request raw material traceability — For GLP-1 peptides and other high-value sequences, ask about raw material sourcing to ensure supply chain reliability.
Frequently Asked Questions
Q1: What is the cost range for a standard 15-mer peptide at 98% purity?
For a standard 15-amino-acid linear peptide at 98% purity, expect $80–150 per gram at the 10 mg scale, dropping to $50–80/g at 100 mg scale, and $20–40/g at gram scale. These prices assume a standard sequence without difficult couplings.
Q2: How much more does a disulfide bridge add to synthesis cost?
One disulfide bridge adds approximately 20–35% to the total cost. Two disulfide bridges can add 40–60%. Each additional bridge requires a separate oxidation step and increases purification difficulty.
Q3: Does longer sequence mean proportionally higher cost?
Not linearly. Cost scales roughly quadratically with sequence length: a 30-mer is often 5–8x more expensive than a 10-mer due to lower coupling efficiency and increased purification difficulty.
Q4: Is there a minimum cost regardless of peptide size?
Yes. Most manufacturers have a minimum project fee of $300–800 covering sequence verification, resin setup, and QC testing. Ultra-short sequences (<5 aa) may cost more per residue due to this overhead.
Q5: Do Chinese peptide manufacturers offer cost advantages?
Yes. Chinese manufacturers typically offer 30–60% cost advantages over US/European suppliers for equivalent quality. At AmPepitide, we provide transparent, itemized pricing with full analytical documentation.
For researchers requiring high-purity peptides with full analytical documentation including HPLC and LC-MS traces, browse our complete peptide product catalog for bulk pricing and specifications on all research compounds.
Conclusion
Custom peptide synthesis pricing is determined by a multidimensional cost matrix. Sequence length, purity grade, modifications, scale, timeline, counterion, and synthesis difficulty all contribute to the final price. Understanding these factors helps researchers make informed decisions that balance budget constraints with experimental requirements.
At AmPepitide, we provide transparent, itemized pricing for every custom synthesis project — from simple linear peptides to complex multi-modified sequences. Contact our custom synthesis team with your sequence for a competitive quote within 24 hours, and we will walk you through the optimal purity, scale, and modification options for your specific research needs.
